Philadelphia FIGHT is a Philadelphia AIDS service organization that provides primary care, consumer education, advocacy and research. FIGHT was formed as a partnership of individuals living with HIV & AIDS and clinicians.

During the past decade, Philadelphia FIGHT conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 14 clinical trials were completed, i.e. on average, 127.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 4 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Philadelphia FIGHT" #1 sponsor was "Gilead Sciences" with 19 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 19 trials sponsored, "Abbott" with 3 trials sponsored, "Philadelphia Fight" with 2 trials sponsored and "ViiV Healthcare" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Philadelphia FIGHT" #1 collaborator was "Gilead Sciences" with 1 trials as a collaborator, "Glaxo Wellcome" with 1 trials as a collaborator, "Janssen Research & Development, LLC" with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Philadelphia FIGHT" are "HIV Infections" (40 trials), "HIV-1 Infection" (7 trials), "Acquired Immunodeficiency Syndrome" (5 trials), "HIV" (5 trials) and "Mycobacterium Avium-intracellulare Infection" (3 trials). Many other conditions were trialed in "Philadelphia FIGHT" in a lesser frequency.

Most popular intervention types in "Philadelphia FIGHT" are "Drug" (45 trials), "Behavioral" (2 trials), "Biological" (1 trials), "Device" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "FTC/TDF" (5 trials), "Indinavir sulfate" (5 trials), "Efavirenz" (4 trials), "Nelfinavir mesylate" (4 trials) and "RTV" (4 trials). Other intervention names were less common.

The vast majority of trials in "Philadelphia FIGHT" are 55 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Philadelphia FIGHT". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 51 completed trials in Philadelphia FIGHT, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Philadelphia FIGHT, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 30 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 9 trials that are defined as “Not Applicable".